FDAnews
www.fdanews.com/articles/75374-viventia-announces-3-3-million-interim-financing

VIVENTIA ANNOUNCES $3.3 MILLION INTERIM FINANCING

August 15, 2005

Viventia Biotech Inc. (TSX:VBI) today announced that its board of directors has ratified two interim bridge loans, for $900,000 and $2 million obtained on July 26, 2005 and August 3, 2005 respectively, from Mr. Leslie Dan, the Company's Chairman and an entity controlled by him. In addition, the Board of Directors approved and authorized the Company to obtain an additional interim bridge loan of $400,000 from Mr. Dan to fund ongoing operations. All of the loans are unsecured, have an interest rate of 4.5% per year and are repayable on demand.

()a href="http://www.newswire.ca/en/releases/archive/August2005/12/c9926.html" target="_blank">Canada NewsWire Group